Suppr超能文献

重症肌无力危象作为肌肉特异性激酶阳性重症肌无力的首发表现:一例报告

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report.

作者信息

Chhetri Dipesh, Bhattarai Amit Sharma, Joshi Pankaj, Thapa Kriti

机构信息

Chirayu National Hospital and Medical Institute, Basundhara, Kathmandu, Nepal.

Department of Anaesthesiology, Maharajgunj Medical Campus, Maharajgunj, Kathmandu, Nepal.

出版信息

JNMA J Nepal Med Assoc. 2025 Mar;63(283):179-181. doi: 10.31729/jnma.8896. Epub 2025 Mar 31.

Abstract

We report a unique presentation of a 57-year-old female presented with severe respiratory acidosis, which was found to be a case of Musk-positive Myasthenia Gravis. Patient presented with depressed level of consciousness and respiratory failure, mandating urgent ventilatory support. She responded well with positive pressure ventilation. However, she persistently failed to maintain adequate ventilation after extubation and had to be reintubated. At presentation, the absence of classical symptoms typical of Myasthenia Gravis posed a diagnostic dilemma, initially obscuring the underlying etiology. However, since there was no other identifiable cause for the inability to maintain ventilation, antibody panels were sent which turned out positive for Muscle specific kinase. This case thus highlights the significance of considering atypical neuromuscular presentations, particularly when respiratory compromise is the predominant manifestation, highlighting the necessity for comprehensive neurological evaluation even in the absence of classical symptoms for timely diagnosis and management of Myasthenia Gravis.

摘要

我们报告了一例独特的病例,一名57岁女性出现严重呼吸性酸中毒,结果发现是肌肉特异性激酶(Musk)阳性的重症肌无力病例。患者表现为意识水平下降和呼吸衰竭,需要紧急通气支持。她对正压通气反应良好。然而,拔管后她持续无法维持足够的通气,不得不重新插管。就诊时,缺乏重症肌无力的典型症状构成了诊断难题,最初掩盖了潜在病因。然而,由于没有其他可识别的导致无法维持通气的原因,于是进行了抗体检测,结果发现肌肉特异性激酶呈阳性。因此,该病例凸显了考虑非典型神经肌肉表现的重要性,尤其是当呼吸功能不全是主要表现时,强调了即使没有典型症状,也需要进行全面的神经学评估,以便及时诊断和管理重症肌无力。

相似文献

2
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.依奈利珠单抗治疗全身型重症肌无力的3期试验。
N Engl J Med. 2025 Jun 19;392(23):2309-2320. doi: 10.1056/NEJMoa2501561. Epub 2025 Apr 8.
3
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002277. doi: 10.1002/14651858.CD002277.pub4.
4
Plasma exchange for myasthenia gravis.用于重症肌无力的血浆置换
Cochrane Database Syst Rev. 2002;2002(4):CD002275. doi: 10.1002/14651858.CD002275.
5
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2003(2):CD002277. doi: 10.1002/14651858.CD002277.
6
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2008 Jan 23(1):CD002277. doi: 10.1002/14651858.CD002277.pub3.
7
Intravenous immunoglobulin for myasthenia gravis.静脉注射免疫球蛋白治疗重症肌无力
Cochrane Database Syst Rev. 2006 Apr 19(2):CD002277. doi: 10.1002/14651858.CD002277.pub2.

本文引用的文献

2
Myasthenic crisis.肌无力危象。
Muscle Nerve. 2023 Jul;68(1):8-19. doi: 10.1002/mus.27832. Epub 2023 Apr 28.
9
Myasthenic crisis.重症肌无力危象
Neurohospitalist. 2011 Jan;1(1):16-22. doi: 10.1177/1941875210382918.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验